Boston Partners Increases Position in Cigna Group $CI

Boston Partners boosted its holdings in Cigna Group (NYSE:CI) by 314.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,638,191 shares of the health services provider’s stock after purchasing an additional 1,243,056 shares during the quarter. Boston Partners’ holdings in Cigna Group were worth $450,856,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Storgate LLC purchased a new stake in Cigna Group in the fourth quarter worth about $719,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cigna Group by 1.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,325,173 shares of the health services provider’s stock worth $639,957,000 after purchasing an additional 23,202 shares during the period. Gator Capital Management LLC purchased a new stake in Cigna Group in the fourth quarter worth about $2,028,000. Wealthspire Advisors LLC grew its holdings in shares of Cigna Group by 147.4% during the fourth quarter. Wealthspire Advisors LLC now owns 4,100 shares of the health services provider’s stock valued at $1,128,000 after buying an additional 2,443 shares during the last quarter. Finally, Allianz SE grew its holdings in shares of Cigna Group by 6.9% during the fourth quarter. Allianz SE now owns 26,040 shares of the health services provider’s stock valued at $7,167,000 after buying an additional 1,673 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Cigna Group Trading Up 1.0%

Shares of CI stock opened at $297.77 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The firm has a fifty day moving average price of $282.53 and a 200-day moving average price of $278.01. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $78.77 billion, a price-to-earnings ratio of 12.62, a PEG ratio of 1.14 and a beta of 0.28.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter in the previous year, the firm posted $6.74 EPS. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is presently 26.45%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CI shares. Jefferies Financial Group cut their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Mizuho increased their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Cantor Fitzgerald increased their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Morgan Stanley increased their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Finally, Piper Sandler cut their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.